Arsenite retards the cardiac differentiation of rat cardiac myoblast H9c2 cells.

[1]  Tyler R. McClintock,et al.  Arsenic Exposure from Drinking Water and QT-Interval Prolongation: Results from the Health Effects of Arsenic Longitudinal Study , 2013, Environmental health perspectives.

[2]  B. Jackson,et al.  Effects of Low-Dose Drinking Water Arsenic on Mouse Fetal and Postnatal Growth and Development , 2012, PloS one.

[3]  A. Sugawara,et al.  All‐trans retinoic acid and a novel synthetic retinoid tamibarotene (Am80) differentially regulate CD38 expression in human leukemia HL‐60 cells: possible involvement of protein kinase C‐δ , 2011, Journal of leukocyte biology.

[4]  Takahiko Sasaki,et al.  Rat H9c2 cardiac myocytes are sensitive to arsenite due to a modest activation of transcription factor Nrf2 , 2011, Archives of Toxicology.

[5]  P. Oliveira,et al.  Isoproterenol Cytotoxicity is Dependent on the Differentiation State of the Cardiomyoblast H9c2 Cell Line , 2011, Cardiovascular Toxicology.

[6]  L. Bain,et al.  Sodium arsenite delays the differentiation of C2C12 mouse myoblast cells and alters methylation patterns on the transcription factor myogenin. , 2011, Toxicology and applied pharmacology.

[7]  A. Cataldi,et al.  PKC-δ signalling pathway is involved in H9c2 cells differentiation. , 2010, Differentiation; research in biological diversity.

[8]  K. Tsai,et al.  Arsenic Inhibits Myogenic Differentiation and Muscle Regeneration , 2010, Environmental health perspectives.

[9]  Y. Hsueh,et al.  Increased risk of QT prolongation associated with atherosclerotic diseases in arseniasis-endemic area in southwestern coast of Taiwan. , 2009, Toxicology and applied pharmacology.

[10]  Zongfu Cao,et al.  Developmental mechanisms of arsenite toxicity in zebrafish (Danio rerio) embryos. , 2009, Aquatic toxicology.

[11]  L. Chai,et al.  Resveratrol protects against arsenic trioxide‐induced cardiotoxicity in vitro and in vivo , 2008, British journal of pharmacology.

[12]  D. Brooks,et al.  Arsenic exposure in pregnant mice disrupts placental vasculogenesis and causes spontaneous abortion. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  Honglin Luo,et al.  Apoptosis repressor with caspase recruitment domain (ARC) inhibits myogenic differentiation , 2007, FEBS letters.

[14]  R. Kwok,et al.  Chronic Arsenic Exposure and Cardiac Repolarization Abnormalities with QT Interval Prolongation in a Population-based Study , 2007, Environmental health perspectives.

[15]  David S. Paul,et al.  Molecular Mechanisms of the Diabetogenic Effects of Arsenic: Inhibition of Insulin Signaling by Arsenite and Methylarsonous Acid , 2007, Environmental health perspectives.

[16]  Y. J. Kang,et al.  Myocardial toxicity of arsenic trioxide in a mouse model , 2007, Cardiovascular Toxicology.

[17]  S. Tsui,et al.  Calcyclin binding protein promotes DNA synthesis and differentiation in rat neonatal cardiomyocytes , 2006, Journal of cellular biochemistry.

[18]  Steve Selvin,et al.  Increased Mortality from Lung Cancer and Bronchiectasis in Young Adults after Exposure to Arsenic in Utero and in Early Childhood , 2006, Environmental health perspectives.

[19]  Qiao Wu,et al.  The role of Akt on Arsenic trioxide suppression of 3T3-L1 preadipocyte differentiation , 2005, Cell Research.

[20]  P. Sims,et al.  Protein kinase C (cid:1) mediates retinoic acid and phorbol myristate acetate–induced phospholipid scramblase 1 gene expression: its role in leukemic cell differentiation , 2004 .

[21]  G. Castoria,et al.  Differentiation of H9c2 cardiomyoblasts: The role of adenylate cyclase system , 2004, Journal of cellular physiology.

[22]  A. Cheng,et al.  Direct cardiac effects of As2O3 in rabbits: evidence of reversible chronic toxicity and tissue accumulation of arsenicals after parenteral administration. , 2003, Toxicology and applied pharmacology.

[23]  K. Tang,et al.  Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro , 2003, Journal of cellular biochemistry.

[24]  R. Ohno,et al.  Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring , 2002, Leukemia.

[25]  Guoqiang Chen,et al.  Arsenic trioxide, a therapeutic agent for APL , 2001, Oncogene.

[26]  T. Ley,et al.  Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. , 2001, Blood.

[27]  S. A. Ahmad,et al.  Arsenic in drinking water and pregnancy outcomes. , 2001, Environmental health perspectives.

[28]  I Hertz-Picciotto,et al.  Chronic arsenic exposure and risk of infant mortality in two areas of Chile. , 2000, Environmental health perspectives.

[29]  P. Lory,et al.  Modulation of L-type Calcium Channel Expression during Retinoic Acid-induced Differentiation of H9C2 Cardiac Cells* , 1999, The Journal of Biological Chemistry.

[30]  M. Kazanietz,et al.  New insights into the regulation of protein kinase C and novel phorbol ester receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  A. Smith,et al.  Vascular effects of chronic arsenic exposure: a review. , 1994, Epidemiologic reviews.

[32]  G. Nordberg,et al.  Arsenic and Raynaud's phenomenon , 1988, International archives of occupational and environmental health.

[33]  H. Rumpold,et al.  Alterations of purine salvage pathways during differentiation of rat heart myoblasts towards myocytes. , 1986, Biochimica et biophysica acta.

[34]  W. Tseng,et al.  Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. , 1968, Journal of the National Cancer Institute.